Zila's 3rd-qtr fiscal 2007 loss reduced

Phoenix, USA-based Zila, a specialist screening company focused on the detection of oral cancer, says that for its fiscal third quarter, ended April 30, 2007, its net loss was $4.3 million, a significant improvement on the $8.1 million deficit it recorded in the comparable period in the previous financial year.

Zila said that its $34.0 million acquisition of Pro-Dentec, completed late in 2006, and the subsequent boost to revenues, was key to the loss reduction. The firm cautioned, however, that ongoing systems integration costs associated with the purchase would negatively impact on its fiscal fourth quarter.

Revenues hit $10.8 million